Puma Biotechnology Announces Proposed Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St set to open lower after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Puma Biotech (PBYI) on Watch as Offering Said in Doubt
October 19, 2016 1:25 PM EDTPuma Biotech (NYSE: PBYI) was in focus amid doubts about the success of its $150 million common stock offering.
$PBYI -16%. Im hearing weak investor demand for stock offering announced last night.
Adam Feuerstein (@adamfeuerstein) October 19, 2016... More



